Staging Laparoscopy Not Only Saves Patients an Incision, But May Also Help Them Live Longer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Annals of Surgical Oncology

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-017-6317-1PMID 29388123
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is routine hepaticojejunostomy at the time of unplanned surgical bypass required in the era of self-expanding metal stents?

  2017cited by this paper
• Timing of initiation of adjuvant chemotherapy for gastric cancer: A case-matched comparison study of laparoscopic vs. open surgery.

  2017cited by this paper
• Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.

  2016cited by this paper
• Cost-effectiveness of diagnostic laparoscopy for assessing resectability in pancreatic and periampullary cancer

  2015cited by this paper
• Staging laparoscopy in patients scheduled for pancreaticoduodenectomy minimizes hospitalization in the remaining life time when metastatic carcinoma is found.

  2014cited by this paper
• Cost‐effectiveness of laparoscopy versus laparotomy for initial surgical evaluation and treatment of potentially resectable hepatic colorectal metastases: a decision analysis

  2008cited by this paper
• Cost-effectiveness of laparoscopy versus laparotomy for initial surgical evaluation and treatment of potentially resectable hepatic colorectal metastases: A decision analysis

  2007cited by this paper
• Addition of prophylactic gastrojejunostomy to hepaticojejunostomy significantly reduces gastric outlet obstruction in people with unresectable periampullary cancer.

  2004cited by this paper
• The Need for a Prophylactic Gastrojejunostomy for Unresectable Periampullary Cancer: A Prospective Randomized Multicenter Trial With Special Focus on Assessment of Quality of Life

  2003cited by this paper
• Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial.

  1999cited by this paper
• Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass.

  1999cited by this paper
• Experience with staging laparoscopy in pancreatic malignancy.

  1999cited by this paper
• EndoScope: world literature reviews

  1996cited by this paper
• Role of prophylactic gastroenterostomy for unresectable pancreatic carcinoma.

  1995cited by this paper
• Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer

  1995cited by this paper
• Malignant biliary obstruction: efficacy of thin-section dynamic CT in determining resectability.

  1992cited by this paper
• Surgical Palliation for Pancreatic Cancer: The UCLA Experience

  1990cited by this paper
• Preoperative staging and assessment of resectability of pancreatic cancer.

  1990cited by this paper
• Surgical palliation for pancreatic cancer.

  1989cited by this paper
• Laparoscopy in the staging and planning of therapy for pancreatic cancer.

  1986cited by this paper

• Staging laparoscopy to detect occult metastases in localized pancreatic cancer: global survey among nine international societies.

  2025cites this paper
• Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future

  2025cites this paper
• Role of preoperative circulating tumor DNA in predicting occult metastases in resectable and borderline resectable pancreatic ductal adenocarcinoma

  2025cites this paper
• Update to the role of staging laparoscopy in the assessment of resectability of perihilar cholangiocarcinoma: have improvements in cross-sectional and functional imaging rendered it redundant?

  2025cites this paper
• Patientensicherheit in der palliativen Chirurgie

  2025cites this paper
• Patientensicherheit in der palliativen Chirurgie

  2025cites this paper
• Multimodal Therapy for Pancreatic Cancer: State of the Art.

  2025cites this paper
• Cost-effectiveness of staging laparoscopy with peritoneal cytology in pancreatic adenocarcinoma.

  2024cites this paper
• Benefits of neoadjuvant chemotherapy with gemcitabine plus S-1 for resectable pancreatic ductal adenocarcinoma

  2024cites this paper
• Use of Diagnostic Laparoscopy and Peritoneal Washings for Pancreatic Cancer.

  2024cites this paper
• Surgery for Locally Advanced Pancreatic Cancer Following Induction Chemotherapy: A Single-Center Experience

  2024cites this paper
• Scoring system to predict positive peritoneal cytology in patients with resectable and borderline resectable pancreatic cancer

  2024cites this paper
• Multimodal Approaches to Patient Selection for Pancreas Cancer Surgery

  2024cites this paper
• Preoperative predictive factors for positive peritoneal cytology results in patients with pancreatic ductal adenocarcinomas: a retrospective study

  2024cites this paper
• Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study

  2024cites this paper
• Development of a Deep Learning System for Intraoperative Identification of Cancer Metastases

  2023cites this paper
• Development of a radiomics-based model to predict occult liver metastases of pancreatic ductal adenocarcinoma: a multicenter study

  2023cites this paper
• A Paradigm Shifts: Neoadjuvant Therapy for Clearly Resectable Pancreatic Cancer

  2023cites this paper
• Surgical management of pancreatic ductal adenocarcinoma: a narrative review

  2023cites this paper
• Aborted cancer surgery at a single tertiary cancer center: Rates, reasons, and outcomes.

  2023cites this paper
• Increased incidence of positive peritoneal lavage cytology early after fine needle aspiration in patients with pancreatic ducal adenocarcinoma.

  2023cites this paper
• Cinematic Rendering: Novel Tool for Improving Pancreatic Cancer Surgical Planning.

  2022cites this paper
• Contemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant Therapy

  2022cites this paper
• Korean Surgical Practice Guideline for Pancreatic Cancer 2022: A summary of evidence-based surgical approaches

  2022cites this paper
• Rates and Outcomes of Aborted Cancer Surgery among Older Patients with Pancreatic Cancer: a SEER-Medicare Study

  2022cites this paper
• The clinical benefits of performing staging laparoscopy for pancreatic cancer treatment.

  2022cites this paper
• Advances in the management of peritoneal malignancies

  2022cites this paper
• Outcomes and risks in palliative pancreatic surgery: an analysis of the German StuDoQ|Pancreas registry

  2022cites this paper
• The yield of staging laparoscopy for resectable and borderline resectable pancreatic cancer in the PREOPANC randomized controlled trial.

  2022cites this paper
• MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy

  2021cites this paper
• Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Abdominal Metastases

  2021cites this paper
• Neoadjuvant Treatment Strategies in Resectable Pancreatic Cancer

  2021cites this paper
• A simple risk score for detecting radiological occult metastasis in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma

  2021cites this paper
• The current role of blood-based biomarkers in surgical decision-making in patients with localised pancreatic cancer: A systematic review.

  2021cites this paper
• Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches.

  2021cites this paper
• Circulating tumor DNA as a predictive marker for occult metastases in pancreatic cancer patients with radiographically non‐metastatic disease

  2021cites this paper
• Staging Classification and Stratification of Pancreatic Cancer for Clinical Practice

  2021cites this paper
• Surgery After Response to Chemotherapy for Locally Advanced Pancreatic Ductal Adenocarcinoma: A Guide for Management.

  2021cites this paper
• The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines

  2021cites this paper
• A nomogram of preoperative predictors for occult metastasis in patients with PDAC during laparoscopic exploration.

  2021cites this paper
• Clinical staging in pancreatic adenocarcinoma underestimates extent of disease.

  2020cites this paper
• Staging laparoscopy is mandatory for the treatment of pancreatic cancer to avoid missing radiologically negative metastases

  2020cites this paper
• Efficacy of Staging Laparoscopy for Pancreatic Cancer

  2020cites this paper
• Clinical usefulness of conversion surgery for unresectable pancreatic cancer diagnosed on multidetector computed tomography imaging: Results from a multicenter observational cohort study by the Hokkaido Pancreatic Cancer Study Group (HOPS UR‐01)

  2019cites this paper
• Conversion surgery for positive peritoneal washing cytology in pancreatic cancer

  2019cites this paper
• Pancreatic cancer surgical management.

  2019cites this paper
• ASO Author Reflections: Staging Laparoscopy Improves Overall Survival of Patients with Pancreatic Adenocarcinoma Found to Have Occult Metastatic Disease

  2018cites this paper
• Editorial: pancreatic resection in the era of laparoscopy: state of art—a systematic review

  2018cites this paper
• Predictors of distant metastasis on exploration in patients with potentially resectable pancreatic cancer

  2018cites this paper